Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Monastrol

Home DrugsMonastrol

Experimental

Small Molecule

Monastrol

Unknown Manufacturer

Generate AI report

Share to Twitter Share to Facebook Share to LinkedIn Share to Reddit

Technical identifiers

Chemical Formula: C₁₄H₁₆N₂O₃S
CAS Number: 254753-54-3
UNII ID: 6BSM97YZ8G

Patents

One entry per invention. Patent families filed in the US, EP, WO and CN offices.

Precursor compound of 18F marked tumor inhibitor Monastrol as well as preparation method and application
CN 101781259 AApplicant: UNIV ZHEJIANGPriority: 2010
CN
Application of Kif11 inhibitor monastrol in inhibiting pathological pain
CN 111358792 AApplicant: 4TH MILITARY MEDICAL UNIV CHINESE PLAPriority: 2020
CN